{"anticipatedPostingDate":"2027-12","denomUnitsSelected":"Participants","description":"An AE was any untoward medical occurrence in a participant or clinical investigational participant administered a medicinal product and which did not necessarily have a causal relationship with this treatment. A TEAE was defined as a newly occurring or worsening AE after the first dose of study treatment.","reportingStatus":"NOT_POSTED","timeFrame":"From first dose of the study treatment (Day 1) up to 30 days after the last dose of study treatment (approximately 52.7 months)","title":"Number of Participants With Treatment Emergent Adverse Events (TEAEs)","type":"SECONDARY"}